Sunday, 5 December 2021

Bangladesh allows phase-3 trial of Chinese vaccine

REUTERS/Mohammad Ponir Hossain

DHAKA: For the second day in a row, the World Health organisation reported a record spike in global covid-19 cases, with 259,848 new cases in the last 24 hours. Most of the new cases were reported from the US, India, Brazil and South Africa.

Bangladesh’s medical regulatory body on Sunday approved the final or phase-3 human trial of a COVID-19 vaccine by a Chinese firm against the deadly disease. The Bangladesh Medical Research Council (BMRC) approved the last stage trial of the vaccine by Chinese firm Sinovac Biotech Ltd as Dhaka-based International Centre for Diarrheal Disease Research, Bangladesh (ICDR’B) submitted a research protocol, seeking to carry out the study.

Check Also

EU antitrust regulators to investigate Google’s online ads business

Alphabet unit Google has found itself in the EU antitrust spotlight again as regulators opened ...

Leave a Reply